Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels


Bluebird Bio shares were trading higher after the company announced the FDA accepted the Biologics License Application for betibeglogene autotemcel for priority review.


Benzinga | Nov 22, 2021 11:35AM EST

Bluebird Bio shares were trading higher after the company announced the FDA accepted the Biologics License Application for betibeglogene autotemcel for priority review.






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC